Flow Cytometry Sample Processing Packages

Whole blood samples for flow cytometry begin degrading within hours of collection, long before most reach a central lab. For studies measuring protein phosphorylation or receptor occupancy, that instability puts drug mechanism-of-action and binding data at risk. Resolian’s sample processing package extends stability to 47 days, turning a logistics problem into a controlled, batchable process.

FLOW CYTOMETRY

CASE STUDY

Our Approach: Stabilise, Batch, Ship

Our Flow Cytometry team have designed a sample processing package that solves this problem.

The process involves:

» Stabilising sample before shipping

» Batch samples from one

» Decrease variability

Packages

Split Processing in Practice

At the sample collection site:

» Start with the Resolian Sample Processing Package Kits

» Follow the Lab Manual

» Freeze and Ship

Process

What’s in the Sample Processing Kit

Resolian provide kits containing everything the sample collection site needs:

  1. Pre-measured reagents, ready to use on receipt
  2. Pre-made buffers, supplied by the manufacturer or Resolian
  3. All other consumables needed for collection and stabilisation
  4. A step-by-step lab manual, written for entry-level lab skills, so any trained analyst can run the process

Stability Data: Up to 47 Days Post-Sample

Freshly Lysed Blood represents traditional way of doing this. In the graph below we are showing up to 35 days post sample. The graph below shows data at 47 days with the error bars representing the replicate analysis with CV ranges between 9.4-6.2 and MdFI CV ranges between 2.0-4.7.

Graphs 1
Graphs 2

Designed for Any Lab-Trained Analyst 

The package we have designed can be used by any lab-trained staff.

For example, an analyst. Shown below is an example of a method-naive analyst generally trained in lab procedures, compared to analyst primarily working on the project.

Graphs 3

Beyond Phosphorylation: Receptor Occupancy Assays

The concept of split processing works for Receptor Occupancy Assay with unique order and stabilisation:

Graphs 4
Graphs 5
Benefits

The Practical Difference

  1. Lower Batch Fees. We can now batch samples into larger batches without concerns over stability.
  2. Reduced Variability. Batching per subject reduces variability as the same reagent, instrument, day, and run will be used.
  3. Repeat Analysis. We have the luxury to repeat analysis if a batch fails.
  4. Automation. Batching allows us to use automation more regularly further reducing fees and improving precision.
  5. Multiple Centre Studies. We can handle studies conducted in multiple locations. Customs and shipping delays do not affect the samples and results.
  6. Low Logistics Costs. Samples can be shipped in fewer packages, reducing costs.

 

It Takes a Team, Working Fast, to Get This Right

Samples reach our lab within 15 minutes of arrival on site.

Our team works nights and weekends when studies demand it,
backed by courier and central lab relationships built over years, not weeks.

Every result passes through analysts, scientists, and a scientific director before it reaches you.

That’s the difference between a sample processing package and a partner. 

Scroll to Top
Zhao. Resolian Bioanalytics and Analytical Sciences.

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett. Resolian Bioanalytics and Analytical Sciences.

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.